CRISPR-Cas9-mediated genome editing in Leishmania donovani

mBio

Volumn 6, Issue 4, 2015, Pages

  Zhang, Wen Wei ^a   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; ENDONUCLEASE; GUIDE RNA; MILTEFOSINE; OLIGONUCLEOTIDE; PROTEIN CAS9; RIBOSOME RNA; RIBOZYME; UNCLASSIFIED DRUG;

ARTICLE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG RESISTANCE; EXPRESSION VECTOR; GENE; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENETIC ENGINEERING; GENOME EDITING; HEPATITIS DELTA VIRUS; HOMOLOGY DIRECTED REPAIR; LDMT GENE; LEISHMANIA DONOVANI; MICROHOMOLOGY MEDIATED END JOINING; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; STOP CODON; CRISPR CAS SYSTEM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; GENOME; METABOLISM; PROCEDURES;

CRISPR-CAS SYSTEMS; GENE TARGETING; GENETIC VECTORS; GENOME, PROTOZOAN; LEISHMANIA DONOVANI; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; RNA, CATALYTIC;

EID: 84940827347     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00861-15     Document Type: Article

References (58)

1. Doudna JA, Charpentier E. 2014. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096. http://dx.doi.org/10.1126/science.1258096
2. Harrison MM, Jenkins BV, O’Connor-Giles KM, Wildonger J. 2014. A CRISPR view of development. Genes Dev 28:1859–1872. http://dx.doi.org/10.1101/gad.248252.114
3. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157:1262–1278. http://dx.doi.org/10.1016/j.cell.2014.05.010
4. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821. http://dx.doi.org/10.1126/science.1225829
5. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823. http://dx.doi.org/10.1126/science.1231143
6. Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, Ishitani R, Zhang F, Nureki O. 2014. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156:935–949. http://dx.doi.org/10.1016/j.cell.2014.02.001
7. Böttcher R, Hollmann M, Merk K, Nitschko V, Obermaier C, Philippou-Massier J, Wieland I, Gaul U, Förstemann K. 2014. Efficient chromosomal gene modification with CRISPR/cas9 and PCR-based homologous recombination donors in cultured Drosophila cells. Nucleic Acids Res 42:e89. http://dx.doi.org/10.1093/nar/gku289
8. Paix A, Wang Y, Smith HE, Lee CY, Calidas D, Lu T, Smith J, Schmidt H, Krause MW, Seydoux G. 2014. Scalable and versatile genome editing using linear DNAs with microhomology to Cas9 sites in Caenorhabditis elegans. Genetics 198:1347–1356. http://dx.doi.org/10.1534/genetics.114.170423
9. Lin S, Staahl B, Alla RK, Doudna JA. 2014. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/ Cas9 delivery. Elife 3:e04766. http://dx.doi.org/10.7554/eLife.04766
10. Shen B, Brown KM, Lee TD, Sibley LD. 2014. Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9. mBio 5(3): e01114-14. http://dx.doi.org/10.1128/mBio.01114-14
11. Ghorbal M, Gorman M, Macpherson CR, Martins RM, Scherf A, Lopez-Rubio JJ. 2014. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat Biotechnol 32:819–821. http://dx.doi.org/10.1038/nbt.2925
12. Wagner JC, Platt RJ, Goldfless SJ, Zhang F, Niles JC. 2014. Effi- cient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat Methods 11:915–918. http://dx.doi.org/10.1038/nmeth.3063
13. Peng D, Kurup SP, Yao PY, Minning TA, Tarleton RL. 2015. CRISPRCas9- mediated single-gene and gene family disruption in Trypanosoma cruzi. mBio 6(1):e02097-14. http://dx.doi.org/10.1128/mBio.02097-14
14. Sollelis L, Ghorbal M, MacPherson CR, Martins RM, Kuk N, Crobu L, Bastien P, Scherf A, Lopez-Rubio JJ, Sterkers Y. 19 June 2015. First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites. Cell Microbiol http://dx.doi.org/10.1111/cmi.12456
15. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M, WHOLeishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671. http://dx.doi.org/10.1371/journal.pone.0035671
16. Ready PD. 2014. Epidemiology of visceral leishmaniasis. Clin Epidemiol 6:147–154. http://dx.doi.org/10.2147/CLEP.S44267
17. Peacock CS, Seeger K, Harris D, Murphy L, Ruiz JC, Quail MA, Peters N, Adlem E, Tivey A, Aslett M, Kerhornou A, Ivens A, Fraser A, Rajandream MA, Carver T, Norbertczak H, Chillingworth T, Hance Z, Jagels K, Moule S. 2007. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39:839–847. http://dx.doi.org/10.1038/ng2053
18. Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, de Doncker S, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schönian G, Stark O, Sundar S, Vanaerschot M, Hertz- Fowler C, Dujardin JC, Berriman M. 2011. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insight into population structure and mechanisms of resistance. Genome Res 21: 2143–2156. http://dx.doi.org/10.1101/gr.123430.111
19. Rogers MB, Hilley JD, Dickens NJ, Wilkes J, Bates PA, Depledge DP, Harris D, Her Y, Herzyk P, Imamura H, Otto TD, Sanders M, Seeger K, Dujardin JC, Berriman M, Smith DF, Hertz-Fowler C, Mottram JC. 2011. Chromosome and gene copy number variations allow major structural change between species and strains of Leishmania. Genome Res 21: 2129–2142. http://dx.doi.org/10.1101/gr.122945.111
20. Zhang WW, Ramasamy G, McCall LI, Haydock A, Ranasinghe S, Abeygunasekara P, Sirimanna G, Wickremasinghe R, Myler P, Matlashewski G. 2014. Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain. PLoS Pathog 10:e1004244. http://dx.doi.org/10.1371/journal.ppat.1004244
21. Robinson KA, Beverley SM. 2003. Improvements in transfection effi- ciency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol 128:217–228. http://dx.doi.org/10.1016/S0166-6851(03)00079-3
22. Lye LF, Owens K, Shi H, Murta SM, Vieira AC, Turco SJ, Tschudi C, Ullu E, Beverley SM. 2010. Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog 6:e1001161. http://dx.doi.org/10.1371/journal.ppat.1001161
23. Dean S, Sunter J, Wheeler RJ, Hodkinson I, Gluenz E, Gull K. 2015. A toolkit enabling efficient, scalable and reproducible gene tagging in trypanosomatids. Open Biol 5:140197. http://dx.doi.org/10.1098/rsob.140197
24. Wang T, Wei JJ, Sabatini DM, Lander ES. 2014. Genetic screens in human cells using the CRISPR-Cas9 system. Science 343:80–84. http://dx.doi.org/10.1126/science.1246981
25. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. 2014. Genomescale CRISPR-Cas9 knockout screening in human cells. Science 343: 84–87. http://dx.doi.org/10.1126/science.1247005
26. Zhang WW, Charest H, Matlashewski G. 1995. The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins. Nucleic Acids Res 23:4073–4080. http://dx.doi.org/10.1093/nar/23.20.4073
27. Padilla-Mejía NE, Florencio-Martínez LE, Figueroa-Angulo EE, Manning-Cela RG, Hernández-Rivas R, Myler PJ, Martínez-Calvillo S. 2009. Gene organization and sequence analyses of transfer RNA genes in trypanosomatid parasites. BMC Genomics 10:232. http://dx.doi.org/10.1186/1471-2164-10-232
28. Yan S, Lodes MJ, Fox M, Myler PJ, Stuart K. 1999. Characterization of the Leishmania donovani ribosomal RNA promoter. Mol Biochem Parasitol 103:197–210. http://dx.doi.org/10.1016/S0166-6851(99)00126-7
29. Martínez-Calvillo S, Sunkin SM, Yan S, Fox M, Stuart K, Myler PJ. 2001. Genomic organization and functional characterization of the Leishmania major Friedlin ribosomal RNA gene locus. Mol Biochem Parasitol 116:147–157. http://dx.doi.org/10.1016/S0166-6851(01)00310-3
30. Gao Y, Zhao Y. 2014. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. J Integr Plant Biol 56:343–349. http://dx.doi.org/10.1111/jipb.12152
31. Ryan OW, Cate JH. 2014. Multiplex engineering of industrial yeast genomes using CRISPRm. Methods Enzymol 546:473–489. http://dx.doi.org/10.1016/B978-0-12-801185-0.00023-4
32. Papadopoulou B, Roy G, Ouellette M. 1994. Autonomous replication of bacterial DNA plasmid oligomers in Leishmania. Mol Biochem Parasitol 65:39–49. http://dx.doi.org/10.1016/0166-6851(94)90113-9
33. LeBowitz JH, Smith HQ, Rusche L, Beverley SM. 1993. Coupling of poly(A) site selection and trans-splicing in Leishmania. Genes Dev 7:996–1007. http://dx.doi.org/10.1101/gad.7.6.996
34. Pérez-Victoria FJ, Gamarro F, Ouellette M, Castanys S. 2003. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J Biol Chem 278: 49965–49971. http://dx.doi.org/10.1074/jbc.M308352200
35. Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE. 2014. Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol 32:1262–1267. http://dx.doi.org/10.1038/nbt.3026
36. Glover L, McCulloch R, Horn D. 2008. Sequence homology and microhomology dominate chromosomal double-strand break repair in African trypanosomes. Nucleic Acids Res 36:2608–2618. http://dx.doi.org/10.1093/nar/gkn104
37. Glover L, Jun J, Horn D. 2011. Microhomology-mediated deletion and gene conversion in African trypanosomes. Nucleic Acids Res 39: 1372–1380. http://dx.doi.org/10.1093/nar/gkq981
38. Morrical SW. 2015. DNA-pairing and annealing processes in homologous recombination and homology-directed repair. Cold Spring Harb Perspect Biol 7:a016444. http://dx.doi.org/10.1101/cshperspect.a016444
39. Zhang WW, Matlashewski G. 2012. Deletion of an ATP-binding cassette protein subfamily C transporter in Leishmania donovani results in increased virulence. Mol Biochem Parasitol 185:165–169. http://dx.doi.org/10.1016/j.molbiopara.2012.07.006
40. Madeira da Silva L, Beverley SM. 2010. Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity. Proc Natl Acad Sci U S A 107:11965–11970. http://dx.doi.org/10.1073/pnas.1004599107
41. Ota S, Hisano Y, Ikawa Y, Kawahara A. 2014. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish. Genes Cells 19: 555–564. http://dx.doi.org/10.1111/gtc.12154
42. Zhou J, Wang J, Shen B, Chen L, Su Y, Yang J, Zhang W, Tian X, Huang X. 2014. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting. FEBS J 281:1717–1725. http://dx.doi.org/10.1111/febs.12735
43. Chen X, Xu F, Zhu C, Ji J, Zhou X, Feng X, Guang S. 2014. Dual sgRNA-directed gene knockout using CRISPR/Cas9 technology in Caenorhabditis elegans. Sci Rep 4:. http://dx.doi.org/10.1038/srep07581
44. Li W, Teng F, Li T, Zhou Q. 2013. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 31:684–686. http://dx.doi.org/10.1038/nbt.2652
45. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153: 910–918. http://dx.doi.org/10.1016/j.cell.2013.04.025
46. Passos-Silva DG, Rajão MA, Nascimento de Aguiar PH, Vieira-da- Rocha JP, Machado CR, Furtado C. 2010. Overview of DNA repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major. J Nucleic Acids 2010:840768. http://dx.doi.org/10.4061/2010/840768
47. Gantz VM, Bier E. 2015. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science 348: 442–444. http://dx.doi.org/10.1126/science.aaa5945
48. Chapman JR, Taylor MR, Boulton SJ. 2012. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 47:497–510. http://dx.doi.org/10.1016/j.molcel.2012.07.029
49. McVey M, Lee SE. 2008. MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings. Trends Genet 24: 529–538. http://dx.doi.org/10.1016/j.tig.2008.08.007
50. Decottignies A. 2013. Alternative end-joining mechanisms: a historical perspective. Front Genet 4:48. http://dx.doi.org/10.3389/fgene.2013.00048
51. Ubeda JM, Raymond F, Mukherjee A, Plourde M, Gingras H, Roy G, Lapointe A, Leprohon P, Papadopoulou B, Corbeil J, Ouellette M. 2014. Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite Leishmania. PLoS Biol 12:e1001868. http://dx.doi.org/10.1371/journal.pbio.1001868
52. Xie K, Minkenberg B, Yang Y. 2015. Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system. Proc Natl Acad Sci U S A 112:3570–3575. http://dx.doi.org/10.1073/pnas.1420294112
53. Arribere JA, Bell RT, Fu BX, Artiles KL, Hartman PS, Fire AZ. 2014. Efficient marker free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans. Genetics 198:837–846. http://dx.doi.org/10.1534/genetics.114.169730
54. Kim H, Ishidate T, Ghanta KS, Seth M, Conte D, Jr, Shirayama M, Mello CC. 2014. A co-CRISPR strategy for efficient genome editing in Caenorhabditis elegans. Genetics 197:1069–1080. http://dx.doi.org/10.1534/genetics.114.166389
55. Wu X, Kriz AJ, Sharp PA. 2014. Target specificity of the CRISPRCas9 system. Quant Biol 2:59–70
56. Zhang WW, Matlashewski G. 2015. Screening Leishmania donovani complex-specific genes required for visceral disease. Methods Mol Biol 1201:339–361. http://dx.doi.org/10.1007/978-1-4939-1438-8_20
57. Medina-Acosta E, Cross GA. 1993. Rapid isolation ofDNAfrom trypanosomatid protozoa using a simple “mini-prep” procedure. Mol Biochem Parasitol 59:327–329. http://dx.doi.org/10.1016/0166-6851(93)90231-L
58. Zhang WW, Chan KF, Song Z, Matlashewski G. 2011. Expression of a Leishmania donovani nucleotide sugar transporter in Leishmania major enhances survival in visceral organs. Exp Parasitol 129:337–345. http://dx.doi.org/10.1016/j.exppara.2011.09.010.